Dr. Tripathi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Duarte Road
Duarte, CA 91010
Education & Training
UMass Chan - BaystateFellowship, Hematology and Medical Oncology, 2014 - 2017
UMass Chan Medical SchoolResidency, Internal Medicine, 2011 - 2014
Maulana Azad Medical CollegeClass of 2009
Certifications & Licensure
CA State Medical License 2022 - 2026
OK State Medical License 2017 - 2023
MA State Medical License 2011 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Merit Award American Society of Clinical Oncology, 2017
- Chief Fellow Baystate Medical Center, Tufts University, 2016-2017
Clinical Trials
- Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma Start of enrollment: 2020 Feb 17
- Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma Start of enrollment: 2020 Jul 22
Publications & Presentations
PubMed
- 116 citationsEffects of Citrus sinensis (L.) Osbeck epicarp essential oil on growth and morphogenesis of Aspergillus niger (L.) Van Tieghem.Neeta Sharma, Abhishek Tripathi
Microbiological Research. 2008-05-01 - 1 citationsClinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration.Tanya Dorff, Zeynep Zengin, Nicholas Henderson, Alicia Ali, Charles Nguyen
Research Square. 2023-08-10 - 2 citationsAdjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.Andrea B Apolo, Karla V Ballman, Guru Sonpavde, Stephanie Berg, William Y Kim
The New England Journal of Medicine. 2024-09-15
Lectures
- Prognostic significance of CD73 expression in localized renal cell carcinoma (RCC).ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- NT5E expression and the immune landscape of prostate cancer (PC): An analysis from The Cancer Genome Atlas database.ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Press Mentions
Aravive Reports Fourth Quarter and Twelve Months Ended December 31, 2019 Financial Results and Provides Recent Corporate UpdatesMarch 27th, 2020
ASCO 2023: Record Numbers & the Big ShowMay 31st, 2023- MedPage Today – Abhishek Tripathi, MD, on Eligibility Criteria in Advanced Urothelial Cancer TrialsJuly 13th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
